/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

H

HI Brunner

Cincinnati Children's Hospital Medical Center(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

44

Papers

141

Citations

4

h-index

3

i10-index

HI Brunner is an academic researcher from Cincinnati Children's Hospital Medical Center. The author has contributed to research in topics: Autoimmune and Inflammatory Disorders Research & Adolescent and Pediatric Healthcare & Acute Lymphoblastic Leukemia research. The author has an h-index of 4, co-authored 38 publications.

Research Topics

Autoimmune and Inflammatory Disorders Research Adolescent and Pediatric Healthcare Acute Lymphoblastic Leukemia research Rheumatoid Arthritis Research and Therapies Inflammasome and immune disorders

Papers by this author

works

Predictors of response in patients with active systemic JIA (SJIA) receiving canakinumab: an exploratory analysis of pooled 12-week data

2014 · Pediatric Rheumatology · 4 citations

https://doi.org/10.1186/1546-0096-12-s1-o12

Nicolino Ruperto HI Brunner Isabelle Koné‐Paut Bo Magnusson

PReS-FINAL-2188: Insulin sensitivity is improved in sjia children with insulin resistance after tocilizumab treatment: results from the tender study

2013 · Pediatric Rheumatology · 3 citations

https://doi.org/10.1186/1546-0096-11-s2-o23

H. Mirjafari N Ruperto HI Brunner Zbigniew Żuber

PReS-FINAL-2180: Efficacy and safety of tocilizumab (TCZ) in patients with polyarticular-course juvenile idiopathic arthritis (pcJIA): 2-year data from CHERISH

2013 · Pediatric Rheumatology · 2 citations

https://doi.org/10.1186/1546-0096-11-s2-o15

Fabrizio De Benedetti Nicolino Ruperto Zbigniew Żuber R Cuttica

PReS-FINAL-2001: The impact of adalimumab on growth in patients with juvenile idiopathic arthritis

2013 · Pediatric Rheumatology · 2 citations

https://doi.org/10.1186/1546-0096-11-s2-o4

Nicolino Ruperto D. Lovell Kateřina Jarošová Dana Němcová

PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA)

2013 · Pediatric Rheumatology · 2 citations

https://doi.org/10.1186/1546-0096-11-s2-p152

Fabrizio De Benedetti HI Brunner Eileen Baildam Rubén Burgos‐Vargas

PReS-FINAL-2139: Tapering and withdrawal of tocilizumab in patients with systemic JIA in inactive disease: results from an alternative dosing regimen in the tender study

2013 · Pediatric Rheumatology · 1 citations

https://doi.org/10.1186/1546-0096-11-s2-p151

Fabrizio De Benedetti Nicolino Ruperto HI Brunner Alexei A. Grom

Research topics

topics

Autoimmune and Inflammatory Disorders Research

Adolescent and Pediatric Healthcare

Acute Lymphoblastic Leukemia research

Rheumatoid Arthritis Research and Therapies

Inflammasome and immune disorders

Chat about Author

Papers

Chat

Click to start Chat